生物标志物 生物标志物
Beatriz Ramos Lucente1, Isadora Cristina Ribeiro2, Luis E Santos3
1UNICAMP, Jundiaí, São Paulo, Brazil.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
关键阿尔茨海默氏症风险因素APOE ε4基因对脑脊液 (CSF) 的粉样蛋白水平有影响,但对轻度认知障碍或主观认知衰退的个体的血生物标志物没有影响.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 生物标志物研究 生物标志物研究
背景情况:
- 阿尔茨海默病 (AD) 是最常见的神经退行性疾病.
- APOE ε4等位基因是散发性AD的主要遗传风险因素.
- 在早期认知衰退阶段,APOE ε4对粉样β (Aβ) 和陶水平的影响尚不清楚.
研究的目的:
- 研究APOE基因型与血和CSF生物标志物 (Aβ40,Aβ42,p-tau181,t-tau) 的水平之间的关联.
- 确定APOE基因型是否影响轻度认知障碍 (MCI) 和主观认知衰退 (SCD) 患者的生物标志物度.
主要方法:
- 分析了来自64名老年人的血和脑液样本 (MCI,SCD,AD,对照).
- 使用电化学发光和SIMOA免疫测试量化Aβ42,Aβ40,p-tau181和t-tau.
- 通过SNP分析确定APOE基因型,并使用Bonferroni校正的ANOVA评估生物标记差异.
主要成果:
- 与e2ε3基因型相比,具有APOE ε3ε4基因型的个体表现出较低的CSF Aβ42度 (p=0.02).
- 在APOE基因型之间没有观察到血Aβ40,Aβ42,p-tau181或t-tau水平的显著差异.
结论:
- 在这个队列中,APOE基因型不会影响外围AD生物标志物水平.
- APOE ε4等位基因与中枢神经系统粉样蛋白水平的变化有关,特别是中枢神经液Aβ42.2的降低.
- 研究结果证实了APOE ε4在调节中央粉样蛋白病理中的作用,即使是在早期认知衰退阶段.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516